종근당185750

주관 임상 단계 분포

공시 DART 원문

• 2026-06-30지속가능경영보고서등관련사항(자율공시)DART ↗

진행 중인 임상

• 해당없음모집 예정협력· Chronic Coronary Syndrome

  Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome

  NCT07577518
• 1상모집 예정· Ovarian Cancer

  Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

  NCT07532148
• 1/2상모집 중· Advanced Solid Tumors

  A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

  NCT07439094
• 4상모집 예정· Diabete Type 2

  Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients

  NCT07365358
• 1상모집 예정· Benign Prostate Hypertrophy(BPH)

  A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

  NCT07404735
• 1상모집 중· Atopic Dermatitis

  A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

  NCT07358156
• 1상모집 중· Psoriasis

  Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants

  NCT07258745
• 1상모집 중· Advanced Solid Tumors

  Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors

  NCT07215637
• 4상모집 예정· Heart Transplant

  Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

  NCT06942156
• 3상모집 예정· Androgenetic Alopecia

  A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia

  NCT06916793
• 해당없음모집 중협력· Type 2 Diabetes

  A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

  NCT06627322
• 3상모집 중· Essential Hypertension

  Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

  NCT06643819
• 1상모집 예정· Type 2 Diabetes Mellitus

  To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers

  NCT06492655
• 단계 미표기모집 중· Diabetes Mellitus, Type 2

  Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

  NCT06838286
• 2상모집 중협력· Ovarian Cancer

  Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance

  NCT05704621
• 4상모집 중단 (진행 중)· Kidney Transplantation

  Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients

  NCT05193565
• 단계 미표기모집 중단 (진행 중)협력· Acute Myocardial Infarction (AMI)

  SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

  NCT07198191